購物車
幫助
021-54845833/15800441009
技術(shù)規(guī)格
|
Background: |
CBP and p300 are large nuclear proteins that bind to many sequence-specific factors involved in cell growth and/or differentiation, including c-jun and the adenoviral oncoprotein E1A. The protein encoded by this gene associates with p300/CBP. It has in vitro and in vivo binding activity with CBP and p300, and competes with E1A for binding sites in p300/CBP. |
|
Applications: |
WB, IHC |
|
Name of antibody: |
KAT2B |
|
Immunogen: |
Synthesized peptide derived from human P300/CBP. |
|
Full name: |
K(lysine) acetyltransferase 2B |
|
Synonyms： |
CAF; PCAF; P/CAF |
|
SwissProt: |
Q92831 |
|
IHC positive control: |
Human breast carcinoma tissue |
|
IHC Recommend dilution: |
50-100 |
|
WB Predicted band size: |
93 kDa |
|
WB Positive control: |
COLO205 cells lysate |
|
WB Recommended dilution: |
500-3000 |
